Clinical trials
Terminated Testicular Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 4 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt-Ingram Cancer Center | 3 |
| City of Hope Medical Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| OHSU Knight Cancer Institute | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Case Comprehensive Cancer Center | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| CureOne | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Indiana University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Testicular Neoplasms | 28 |
| Neuroblastoma | 12 |
| Burkitt Lymphoma | 11 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Multiple Myeloma | 11 |
| Breast Neoplasms | 10 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Leukemia, Myelomonocytic, Chronic | 10 |
| Leukemia, Neutrophilic, Chronic | 10 |
| Lymphoma, B-Cell, Marginal Zone | 10 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.